CRYSTALLINE FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREFOR

Title:

CRYSTALLINE FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREFOR

Document Type and Number:

WIPO Patent Application WO/2020/007219

Kind Code:

A1

Abstract:

Disclosed in the present invention are a crystalline form of an EGFR inhibitor and a preparation method therefor, and further comprised is an application of the crystalline form in preparing a drug for treating non-small cell lung cancer.

More Like This:

JP2024023337	Aryl, heteroaryl and heterocyclic pharmaceutical compounds for the treatment of medical disorders
JP6434989	Pyridyl piperidine
JP3258677	[Title of Invention] 1-Oxa-3,8-Diaza-4-oxospiro [4.5] Method for Producing Decane Compound

Inventors:

LIU XILE (CN)
ZHANG LU (CN)
DING CHARLES Z (CN)
CHEN SHUHUI (CN)
HU LIHONG (CN)

Application Number:

PCT/CN2019/092987

Publication Date:

January 09, 2020

Filing Date:

June 26, 2019

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MEDSHINE DISCOVERY INC (CN)

International Classes:

C07D498/10; A61K31/505; A61P35/00

Domestic Patent References:

WO2010002845A2	2010-01-07
WO1995003283A1	1995-02-02

Foreign References:

CN108640928A	2018-10-12
CN107955019A	2018-04-24

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: TWO-DEGREE-OF-FREEDOM HETERODYNE GRATING INTERFEROMETRY MEASUREMENT SYSTEM

Next Patent: MULTI-PHASE PARTICLE, AND MANUFACTURING METHOD THEREFOR AND APPLICATION THEREOF